Welcome to Markel Corporation's (MKL-NYSE) Investor Relations section.
Markel Corporation markets and underwrites specialty insurance products and programs to a variety of niche markets. In each of these markets, we seek to provide quality products and excellent customer service so that we remain a market leader. Our financial goals are to earn consistent underwriting profits and superior investment returns to build shareholder value.
For more information about Markel Corporation, please click here.
|02/23/18||Beth Hungate-Noland to join Markel Ventures|
|RICHMOND, Va., Feb. 23, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today that Beth Hungate-Noland will join the company as a Managing Director. Hungate-Noland, who has been a Partner at Williams Mullen for the past 15 years, will join the team at Markel that is responsible for the oversight of the company's Markel Ventures operations.
"Beth has been a valued partner of the Markel Ventures family for many years and played an integral role wi... |
|02/21/18||Markel names Patrick Moylan Managing Director, Medical Product Line|
|RICHMOND, Va., Feb. 21, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today that Patrick Moylan has been named Managing Director, Medical Product Line. Moylan is responsible for Markel's product development and underwriting efforts in the health care space.
Alan Rodrigues, Executive Underwriting Officer, Casualty, stated, "Patrick's extensive insurance industry experience and strong broker relationships are invaluable assets for our team. In h... |
|02/06/18||Markel Reports 2017 Financial Results|
|RICHMOND, Va., Feb. 6, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) reported book value per common share outstanding of $683.55 at December 31, 2017, up 13% from $606.30 at December 31, 2016. Over the five-year period ended December 31, 2017, the compound annual growth in book value per common share outstanding was 11%. Comprehensive income to shareholders was $1.2 billion for the year ended December 31, 2017 compared to $667.0 million in 2016. The combined ratio was 105% in 2017 compared... |
|01/31/18||Markel Announces Conference Call Date And Time|
|RICHMOND, Va., Jan. 31, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today it will hold a conference call on Wednesday, February 7, 2018 beginning at 9:30 am (Eastern Time) to discuss quarterly and year-end results and business developments.
Any person interested in listening to the call should contact Markel's Investor Relations Department at 804-747-0136. Investors, analysts and the general public also may listen to the call free over t... |
|There are currently no events scheduled.|